Saturday, April 16, 2022

mRNA vaccine for Epstein-Barr Virus enters Phase I trial.


 mRNA vaccine for Epstein-Barr Virus enters Phase I trial.

Visit: https://infectious.pencis.com/
Contact us: infectious@pencis.com

#infectiousdiseases #bacteriology #virology #microbiology #medicine #zikavirus #bacteria #epidemiology #immunology #diphtheria #vaccin #tuberculosis #treatment #infection #virus
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New Technology for Transparent Antibacterial Glass Coatings 🧪🪟 | #pencis #researchawards

Introduction Antibacterial thin-film coatings have emerged as an important technological solution for improving hygiene and biosecurity in...